ARIS three-lens brief
Evidence-based stock research on ARIS. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Moved -2.45% yesterday. · 50-day MA below 200-day MA (death-cross regime); price below both.
- Moved -2.45% yesterday.
- 50-day MA below 200-day MA (death-cross regime); price below both.
- Underperforming SPY by 10.4pp over 30 days.
- P/E of 10.4 — trading at a value multiple.
- Reported earnings on 2026-11-04.
ARIS closed at $15.53 (-2.45%) as of 2026-11-12. Market cap: $3.21B. P/E (trailing) 10.4. Price is below the 50-day MA and below the 200-day MA. Positives: p/E of 10.4 — trading at a value multiple.. Concerns: moved -2.45% yesterday.; 50-day MA below 200-day MA (death-cross regime); price below both.. Last quarter: Revenue $295.42M, free cash flow $96.91M.
Why three lenses on ARIS, not one.
A single reasoning model has blind spots it doesn’t know about. We examine ARIS across Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://www.clearpathinvest.app/embed/ARIS" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath ARIS brief"></iframe>